Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Macular Edema Secondary to Central Retinal Vein Occlusion
Clinical Trial
NCT00943072Last updated: 1/9/2026
REGN
Regeneron Pharmaceuticals, Inc.